Trial intelligence / Profile preview

VRD induction followed by BuMel versus MEL-200 autologous transplant conditioning in newly diagnosed symptomatic multiple myeloma

2012-005683-10Phase 3Completed

Sponsor

PETHEMA

Start

Jul 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules

Countries

1